CIK 0001689548
- Large accelerated filer
Praxis Precision Medicines, Inc.
Sign in to watch- Ticker
- PRAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-300-8460
- Business address
- 99 HIGH STREET, 30TH FLOOR, BOSTON, MA, 02110
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Commercial Officer acquired 16,800 shares (grant or award)
- 4 Grant or award General Counsel and Secretary acquired 12,400 shares (grant or award)
- 4 Grant or award Principal Accounting Officer acquired 8,200 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 52,800 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 24,512 shares (grant or award)
- 4/A Open-market buy Director bought 250,000 shares at $19.00 ($4,750,000)
- 4 Exercise or conversion Chief Medical Officer acquired 45,000 shares (option exercise)
- 4 Open-market buy Chief Executive Officer bought 3,846 shares at $26.08 ($100,304)
- 4 Exercise or conversion Principal Accounting Officer acquired 12,218 shares (option exercise)
- 4 Conversion 10% owner acquired 7,800,553 shares (conversion)
- 4 Conversion 10% owner acquired 7,800,553 shares (conversion)
- 4 Conversion 10% owner acquired 2,442,080 shares (conversion)
- 4 Conversion Chief Executive Officer acquired 20,604 shares (conversion)
- 4 Conversion Director acquired 2,689,329 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 10 of 11 · 210 filings